Prevalence and Risk Factors of Pneumomediastinum and Subcutaneous Emphysema in COVID-19 Patients: A Retrospective Cohort Study
Open Access
- 19 November 2024
- journal article
- research article
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 17 (9)
Abstract
Background: Pneumomediastinum (PM), the presence of air in the mediastinum, is a rare condition. Severe COVID-19 patients are at an increased risk for PM and subcutaneous emphysema (SCE) due to alveolar rupture from diffuse lung injury. Despite the increased prevalence of PM in COVID-19 patients, the optimal treatment approach remains debated. Objectives: This study investigated the prevalence, outcomes, and associated risk factors for PM and SCE in COVID-19 patients. Methods: In this retrospective cohort study, COVID-19 patients aged 18 - 80 with a positive PCR test and chest CT scan from April to December 2021 were included. Cases of PM and SCE were identified, and an equal number of age, sex, and severity-matched COVID-19 patients were selected as the control group for comparison. Results: Of the 1 557 patients, 89 (5.71%) developed PM. Among these patients, 63 (4.04%) developed SCE. Patients with these complications had significantly longer hospital stays. No significant association was found between comorbidities and the occurrence of PM or SCE. The use of Venturi and non-rebreather masks (OR = 3.075, 95% CI: 1.658 - 5.705), non-invasive ventilation (NIV) (OR = 16.941, 95% CI: 6.545 - 43.851), and invasive mechanical ventilation (IMV) (OR = 5.703, 95% CI: 2.595 - 12.533) were significantly associated with these complications (P < 0.0001). The mortality rate among severe COVID-19 patients with PM was 43.8%, and 47.6% among those with SCE. Conclusions: Pneumomediastinum and SCE are rare complications in COVID-19 patients, associated with prolonged hospitalization. The use of certain respiratory support methods, including NIV and IMV, significantly increased the risk of these complications. Both PM and SCE are linked to high mortality rates, highlighting the need for careful management in affected patients.Keywords
This publication has 30 references indexed in Scilit:
- Incidence and Outcome of Pneumomediastinum in Non-ICU Hospitalized COVID-19 Patients*Critical Care Medicine, 2022
- Pulmonary barotrauma in COVID-19: A systematic review and meta-analysisAnnals of Medicine & Surgery, 2022
- Prevalence and risk factors of barotrauma in Covid-19 patients admitted to an intensive care unit in Kuwait; a retrospective cohort studyAnnals of Medicine & Surgery, 2021
- Clinical Characteristics and Outcome of Pneumomediastinum in Patients with COVID-19 PneumoniaJournal of Laparoendoscopic & Advanced Surgical Techniques, 2021
- Alveolar air leakage in COVID-19 patients: Pneumomediastinum and/or pneumopericardiumHeart & Lung, 2020
- Spontaneous subcutaneous emphysema and pneumomediastinum in non-intubated patients with COVID-19Clinical Imaging, 2020
- PNEUMOMEDIASTINUM IN A CRITICALLY ILL CORONAVIRUS DISEASE 2019 (COVID-19) PATIENTChest, 2020
- RECOGNIZING BAROTRAUMA AS AN UNEXPECTED COMPLICATION OF HIGH FLOW NASAL CANNULAChest, 2019
- Secondary Pneumomediastinum: A Retrospective Comparative AnalysisLung, 2009
- Spontaneous Pneumomediastinum: A Comparative Study and Review of the LiteratureThe Annals of Thoracic Surgery, 2008